Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -2.75 is 95% above its 5-year average of -51.72, near the high end of its 5-year range (-100.38–-2.75).
93.84% above its 12-month average of -44.66.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.76.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 4 comparable quarters.
EARNINGS PER SHARE (EPS)
-2.75
EARNINGS PER SHARE (EPS) AVG TTM
-44.66
EARNINGS PER SHARE (EPS) AVG 3Y
-65.84
EARNINGS PER SHARE (EPS) AVG 5Y
-51.72
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+93.84%
CURRENT VS 3Y AVG
+95.82%
CURRENT VS 5Y AVG
+94.68%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Jade Biosciences, Inc.
Market Cap
$803.67M
Earnings Per Share (EPS)
-2.75
TTM Avg
-44.66
3Y Avg
-65.84
5Y Avg
-51.72
Market Cap
$810.26M
Earnings Per Share (EPS)
-0.23
TTM Avg
-0.22
3Y Avg
-0.29
5Y Avg
-0.62
Market Cap
$789.07M
Earnings Per Share (EPS)
-0.10
TTM Avg
-0.20
3Y Avg
-0.27
5Y Avg
-0.29
Market Cap
$788.43M
Earnings Per Share (EPS)
-1.68
TTM Avg
0.05
3Y Avg
-1.18
5Y Avg
-0.72
Market Cap
$786.00M
Earnings Per Share (EPS)
-0.20
TTM Avg
0.10
3Y Avg
-0.30
5Y Avg
-1.16
Market Cap
$778.43M
Earnings Per Share (EPS)
0.52
TTM Avg
-1.70
3Y Avg
-0.56
5Y Avg
-0.09
Market Cap
$833.76M
Earnings Per Share (EPS)
-3.80
TTM Avg
-6.69
3Y Avg
-9.43
5Y Avg
-9.43
Market Cap
$772.90M
Earnings Per Share (EPS)
-0.15
TTM Avg
-0.39
3Y Avg
-0.55
5Y Avg
-0.57
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Jade Biosciences, Inc. (JBIO) | $803.67M | -2.75 | -44.66 | -65.84 | -51.72 |
| InMode Ltd. (INMD)vs › | $803.29M | 1.23 | 1.87 | 2.02 | 1.86 |
| Ardelyx, Inc. (ARDX)vs › | $810.26M | -0.23 | -0.22 | -0.29 | -0.62 |
| Geron Corporation (GERN)vs › | $789.07M | -0.10 | -0.20 | -0.27 | -0.29 |
| AdaptHealth Corp. (AHCO)vs › | $788.43M | -1.68 | 0.05 | -1.18 | -0.72 |
| Gyre Therapeutics, Inc. (GYRE)vs › | $786.00M | -0.20 | 0.10 | -0.30 | -1.16 |
| Varex Imaging Corporation (VREX)vs › | $778.43M | 0.52 | -1.70 | -0.56 | -0.09 |
| Alumis Inc. (ALMS)vs › | $833.76M | -3.80 | -6.69 | -9.43 | -9.43 |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $772.90M | -0.15 | -0.39 | -0.55 | -0.57 |
| Sana Biotechnology, Inc. (SANA)vs › | $772.26M | -0.75 | -1.06 | -1.25 | -1.46 |
Trailing EPS (TTM)
$-2.75
Forward EPS (Est.)
$-2.95
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -4.06 |
| 2024-12-31 | -85.26 |
| 2023-12-31 | -100.38 |
| 2022-12-31 | -73.67 |
| 2021-12-31 | -32.96 |
| 2020-12-31 | -14.00 |
